Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.
01 1Farmak, a,s
02 1Neuland Laboratories Limited
03 1Amoli Organics (A Division of Umedica Laboratories Pvt. Ltd.)
04 1Aurobindo Pharma Limited
05 1Biocon Limited
06 1CTX Lifesciences Pvt. Ltd.
07 1Cipla Ltd.
08 1Erregierre SpA
09 1Glenmark Life Sciences Limited
10 1Jubilant Pharmova Limited
11 1MSN Laboratories Private Limited
12 1MYLAN LABORATORIES LIMITED
13 1Optimus Drugs Private Limited
14 1Piramal Pharma Limited
15 1SK BIOTEK
16 1SMS Pharmaceuticals Limited
17 1Symed Labs Limited
18 1TAPI Croatia Industries Ltd.
19 1Tianish Laboratories Private Limited
01 8DEFERASIROX
02 10Deferasirox
03 1deferasirox
01 1Czech Republic
02 13India
03 1Italy
04 3U.S.A
05 1Blank
Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.
NDC Package Code : 63278-1070
Start Marketing Date : 2007-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Neuland Laboratories- A dedicated 100% API provider.
NDC Package Code : 58032-2017
Start Marketing Date : 2017-12-14
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62512-0078
Start Marketing Date : 2021-03-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59651-419
Start Marketing Date : 2023-12-14
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53104-7713
Start Marketing Date : 2019-08-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42419-031
Start Marketing Date : 2024-09-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49706-2103
Start Marketing Date : 2012-09-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14501-0049
Start Marketing Date : 2010-03-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59285-010
Start Marketing Date : 2016-03-14
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 11722-040
Start Marketing Date : 2017-12-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
A Deferasirox manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Deferasirox, including repackagers and relabelers. The FDA regulates Deferasirox manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Deferasirox API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Deferasirox manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Deferasirox supplier is an individual or a company that provides Deferasirox active pharmaceutical ingredient (API) or Deferasirox finished formulations upon request. The Deferasirox suppliers may include Deferasirox API manufacturers, exporters, distributors and traders.
click here to find a list of Deferasirox suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Deferasirox as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Deferasirox API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Deferasirox as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Deferasirox and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Deferasirox NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Deferasirox suppliers with NDC on PharmaCompass.
We have 18 companies offering Deferasirox
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
